I think in the short - medium term the better play is BVTI. When it files the BLA and when(if) the FDA approves the headlines will reference BVTI first and foremost. Although, the gap in pps between the two may narrow over the next 3 months.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.